The role of inflammation on atherosclerosis

May 1, 2012

(Medical Xpress) -- European scientists dig into atherosclerotic plaque formation processes to investigate the part played by inflammation and vascular wall remodelling.

Cardiovascular diseases remain a serious health problem necessitating an understanding of the underlying mechanisms and the development of novel diagnostic, preventive and therapeutic strategies. Atherosclerosis is caused by a thickening of the capillary walls due to accumulation of lipids such as cholesterol.

Accumulating evidence indicates that inflammation plays a central role in atherosclerosis. To further delineate the causes of atherosclerosis, the EU-funded Atheroremo project has brought together scientists from an array of disciplines.

Project partners have identified some previously unknown involved in vascular inflammation. Their discovery of a novel role of the Streptococcus mitis in atherosclerosis demonstrates that infection can act as a potential initiator of disease. By dissecting the atherosclerotic plaque, researchers have noticed that expression of inflammatory interferons induces changes in the lining the arteries inducing vascular remodelling. A further intriguing discovery has been the involvement of anti-lipoprotein antibodies in atherosclerosis.

Additionally, the consortium has tested a number of novel treatments including montelukast – a compound used in asthma medication – to prevent arterial wall remodelling. Various anti-inflammatory compounds are currently being tried as potential therapeutic strategies.

The Atheroremo project has also joined a large clinical analysis study of patient genetics to discover several new biomarkers for atherosclerosis risk. These novel predictive lipid molecules will form the basis for patient risk assessment.

Overall, the study results to date provide significant information on the inflammatory mechanisms governing atherosclerotic . This knowledge is expected to have serious implications in the diagnosis and therapy of atherosclerosis patients.

Related Stories

Recommended for you

Natural compound reduces signs of aging in healthy mice

October 27, 2016

Much of human health hinges on how well the body manufactures and uses energy. For reasons that remain unclear, cells' ability to produce energy declines with age, prompting scientists to suspect that the steady loss of efficiency ...

A metabolic switch to turn off obesity

October 27, 2016

You've tried all the diets. No matter: you've still regained the weight you lost, even though you ate well and you exercised regularly! This may be due to a particular enzyme in the brain: the alpha/beta hydrolase domain-6 ...

Scientists develop 'world-first' 3-D mammary gland model

October 27, 2016

A team of researchers from Cardiff University and Monash Biomedicine Discovery Institute has succeeded in creating a three-dimensional mammary gland model that will pave the way for a better understanding of the mechanisms ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.